Patient Portal Market Size, Market Growth Projection to 2023

The growth of the overall patient portals market can be contributed to the federal mandates like meaning use, growing patient centric approach in healthcare delivery, increasing EHR adoption rate, and growing popularity of patient portals among the elderly. 

Objectives of the Study

• To define and measure the global patient portal market on the basis of type, delivery mode, end user, and region
• To identify the key micromarkets1 and their drivers within the global patient portal market, which are expected to show impressive growth opportunities in the coming years
• To identify the market trends and opportunities for all the stakeholders
• To strategically analyze the market structure and profile the key players of the global patient portal market and comprehensively analyze their core competencies
• To track and analyze competitive developments such as product deployments; agreements, alliances, collaborations, and partnerships; new product launches and product enhancements; mergers and acquisitions; expansions; and other strategies (divestment, funding, and product integration)

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49094801

Patient portals are an important form of patient engagement solutions that are gaining popularity across the globe. The use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient & family involvement. 

The patient portal market is projected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1% during the forecast period. 

Top Key Players

Allscripts Healthcare Solutions, Inc. (U.S.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), CureMD (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Greenway Health, LLC (U.S.), Medfusion (U.S.), Epic Corporation Inc. (U.S.), GE Healthcare (U.K.), Intelichart (U.S.) are some of the key players in the patient portal market worldwide.

Endoscopy Equipment Growth Analysis | North America to dominate the market

The global endoscopy equipment market is projected to reach USD 34.82 Billion by 2022 from an estimated USD 25.58 Billion in 2017, at a CAGR of 6.4% during the forecast period

The key factors driving the growth of this market include favorable government initiatives, rising number of hospitals and growing hospital investments in endoscopy facilities, technological advancements, and rising prevalence of diseases that require endoscopy

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the endoscopy equipment market, followed by Europe. 

Factors such as a favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, increasing research activities to improve endoscopy, and implementation of a new funding model for Canadian hospitals are contributing to the large share of North America.

Top Key Players

The key players in the global endoscopy equipment market are Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm (Japan), Medtronic (Ireland), Hoya (Japan), CONMED (US), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), Cogentix Medical (US), and B. Braun (Germany).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html

Medical Aesthetics Market Scope by Different Segments

Scope of the Report

This report categorizes the global medical aesthetics market into the following segments and subsegments:

Medical Aesthetics Market, by Product

• Facial Aesthetic Products
• Body Contouring Devices
• Cosmetic Implants
• Hair Removal Devices
• Skin Aesthetic Devices
• Tattoo Removal Devices
• Thread Lift Products
• Physician-dispensed Cosmeceuticals and Skin Lighteners
• Physician-dispensed Eyelash Products
• Nail Treatment Laser Devices

Medical Aesthetics Market, by End User

• Clinics, Hospitals, and Medical Spas
• Beauty Centers
• Home Care

Medical Aesthetics Market, by Region

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

"Medical Aesthetics Market is projected to reach USD 25.6 billion by 2027 from USD 10.3 billion in 2018, at a CAGR of 10.6%.

The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced and user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of the medical aesthetics market during the forecast period.

Read More @ https://www.marketsandmarkets.com/PressReleases/medical-aesthetics.asp

Healthcare Business Intelligence Market by Top Key Players

Factors such as the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries are expected to drive the growth of the healthcare business intelligence (BI) market.

The healthcare business intelligence (BI) market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% during the forecast period.

IBM and Microsoft are leading players in Healthcare Business Intelligence Market

Microsoft is among the key players in the healthcare business intelligence market. The company focuses on strengthening its R&D efforts to reinvent business productivity and build cloud platforms. It also provides its users with economical and convenient products that are integrated with the latest technological solutions and services. Microsoft’s strategy requires it to continuously invest in data centers and other infrastructure that support the latest devices and services. Also, the company invests a substantial amount of its annual revenue in R&D to offer powerful, flexible, secure, and easy-to-use solutions, which are available on a device or via the cloud. Microsoft mainly focuses on product innovation—in the last three years, the company has launched 6 products in the healthcare BI market

IBM is one of the key players in the healthcare BI market and provides a comprehensive range of solutions for this market. IBM is an innovation-centric company; its R&D expenditure has increased substantially in 2017 as compared to 2015. In 2017, it invested 7.3% of its annual revenue in R&D activities. This significant investment allows the company to offer innovative solutions by adopting new product launches. With an aim to increase its footprint in various sectors, IBM has adopted inorganic strategies, such as acquisitions, collaborations, and partnerships.

Other Key players in healthcare business intelligence (BI) market

The market is highly competitive in nature, with several big as well as emerging players. Prominent players in this market include Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland).

Read More @ https://www.marketsandmarkets.com/PressReleases/healthcare-business-intelligence-bi.asp

Parkinson's Disease Treatment Market : Top Industry Player's Growth and Strategies

The Parkinson’s disease treatment market is fragmented in nature due to the presence of a large number of players. The key players are Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), and Boehringer Ingelheim (Germany).

Expansions, acquisitions, agreements, and product launches were the key strategies followed by players in the Parkinson’s disease treatment market. 

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

AbbVie is a key player in the Parkinson’s disease treatment market. The company focuses on organic growth to strengthen its positon in the market. For instance, in 2015, the company launched Duopa drug for treating Parkinson’s disease.

Teva is one of the key players in the Parkinson’s disease treatment market. The company focuses on organic and inorganic strategies to strengthen its position in the Parkinson’s disease treatment market. For instance, in 2015, the company entered into an agreement with Takeda pharmaceutical company to commercialize rasagiline tablets in the Japan.  

Boehringer Ingelheim is another major player in the Parkinson’s disease treatment market. The company mainly focuses on organic strategies to strengthen its position in the market. In 2015, The company launched a new R&D strategy for the fiscal years 2015–2020. 

The Parkinson’s disease treatment market is projected to reach USD 5.69 Billion by 2022 from an estimated USD 4.24 Billion in 2017, at a CAGR of 6.1%. The major factors driving the growth of this market are Growth in the aging population and the associated increase in the prevalence of Parkinson’s disease and growing government funding and support for research

To Know More @https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Top Industry Players of Global Healthcare Quality Management Market

The global healthcare quality management market is projected to reach USD 3.31 Billion by 2022 from an estimated USD 1.70 Billion in 2017, at a CAGR of 14.2%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64588778

In 2016, Nuance Communications, Inc. (U.S.), Premier, Inc. (U.S.), Truven Health Analytics (U.S.), Quantros, Inc. (U.S.), and Medisolv, Inc. (U.S.) dominated the market.

Nuance Communication, Inc. dominated the global healthcare quality management market in 2016. Nuance’s leading position in the market can be attributed to the wide range of its product portfolio. The company’s quality and risk management solutions include physician quality reporting solutions, eCQMs reporting solutions, patient safety organization reporting solutions, performance analytics, and clinical risk management solutions. 

The company has a strong presence across the globe mainly in the U.S., Australia, Austria, Belgium, Brazil, Canada, China, Germany, Hungary, India, Ireland, Italy, Japan, and the U.K. Approximately 71% of its revenue is generated from the North American region, but European markets such as Germany, the U.K., France, Italy, and Belgium are expected to offer lucrative growth opportunities in the near future. The company adopts different organic and inorganic growth strategies to strengthen its market position.

Truven Health Analytics is at the second position in the global healthcare quality management market. The company is known for its reputation in healthcare data management and analytics. The solutions offered by Truven are capable of monitoring and conducting real-time clinical observations that help providers minimize risk and deliver patient-specific clinical decision support (CDS) at the point of care. The company’s dominance in the market can be attributed to its wide range of product offerings and its strong geographical footprint. In the U.S., a large number of healthcare providers use Truven’s CareDiscovery Quality Measures to report quality measures

To Know More @ https://www.marketsandmarkets.com/Market-Reports/healthcare-quality-management-market-64588778.html

Scope of Clinical Workflow Solutions Market During 2018-23

 The global clinical workflow solutions market is projected to reach USD 12.1 billion by 2023 from USD 6.8 billion in 2018, at a CAGR of 12.4%. 

Clinical Workflow Solutions Market by Product (Data Integration, EMR Integration, Nurse Call Systems, Unified Communications, Care Solutions, Patient Flow Management, Enterprise Solutions), End Users, and Region - Global Forecast to 2023

The growth of this market is mainly driven by the increase in need to curtail healthcare costs and the increasing patient volume due to the rising prevalence of chronic diseases. Also, the advantages of clinical workflow solutions in enhancing patient care and safety along with the government initiatives for HCIT adoption are escalating the market growth.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146901412

Recent Developments

• In 2018, Infor launched the Healthcare Enterprise Analytics solution and the Infor Cloverleaf Integration Suite 6.2 version.
• In 2016 Cerner opened a Healthe center at the Cerner Center in Bangalore, India, which helped the company enter the Indian market and also expand its geographic reach.
• In 2016, Infor, Adobe, and Topline collaborated to form the H3 Solution, which includes AEM from Adobe, Cloverleaf from Infor, and Codeable LanguageTM from Topline Healthcare.
• In 2015, Cerner acquired the assets of Siemens Health Services, with an aim to expand its market share, enhance its R&D capabilities, and enter into new markets.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/clinical-workflow-solution-market-146901412.html

Particle Counters Market by End User- 2021

The particle counters market is projected to reach USD 330.6 Million by 2021 from USD 275.9 Million in 2016, at a CAGR of 3.7%. other end users

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221564539

On the basis of end user, the particle counters market is segmented into healthcare industry, semiconductor industry, automotive industry, aerospace industry, food and beverage industry, and other end users. 

In 2016, the healthcare industry commanded the largest share of the market. This large share of this segment can be attributed to the rising pharmaceutical industry and increasing R&D expenditure. 

The market for the semiconductor industry is expected to grow at the highest CAGR in the market during the forecast period. Technological advances of semiconductors and rapidly growing Asian market are driving the growth of this industry.

The growth of the market can be attributed to the growing pharmaceutical and semiconductor industries, increasing spending on pharmaceutical R&D, and growing manufacturing industries in emerging nations.

Stakeholders in the Particle Counters Market:

• Particle Counters Manufacturing Companies
• Suppliers and Distributors of Particle Counters
• Healthcare Companies, Automotive Companies, and Semiconductor Companies
• Research and Consulting Firms
• Research Institutes
• Venture Capitalists

To Know More @ https://www.marketsandmarkets.com/Market-Reports/particle-counter-market-221564539.html

Clinical Trial Supplies Market Analysis by Different Segments

By Products and Services

• Manufacturing
• Packaging and Labeling
• Logistics and Distribution

By Phase

• Phase I
• Phase II
• Phase III

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS And Mental Disorders
• Dermatology
• Blood Disorders
• Infectious Diseases
• Others.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1%. 

The global market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.

The major players in the market are Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html

Point of Care Molecular Diagnostics Market Growing at a CAGR of 14.7%

The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%

The scope of the study includes POC molecular diagnostics analyzers and assays that enable healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127

The key players in the global Point of care molecular diagnostics market are, Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Target Audience:

• POC Molecular Diagnostics Manufacturers
• Physicians
• Research Institutes
• Diagnostics Suppliers
• Market Research and Consulting Firms
• Regulatory Bodies
• Venture Capitalists

The POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others technologies. In 2018, the RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market. 

The large share of this segment can be attributed to the growing use of RT-PCR in proteomics and genomics and access to portable, easy-to-use devices. In the last three years from 2015, more than 42 RT-PCR based products have been launched for various diseases.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Patient Portal Market : Growth Opportunities | Market Analysis | Business Strategies

The patient portal market is projected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1% during the forecast period.

Patient portals are an important form of patient engagement solutions that are gaining popularity across the globe. The use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient & family involvement.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49094801

 The growth of the overall patient portals market can be contributed to the federal mandates like meaning use, growing patient centric approach in healthcare delivery, increasing EHR adoption rate, and growing popularity of patient portals among the elderly. 

On the other hand, data security & privacy concerns, high cost of deployment of patient portal solutions, and requirement of infrastructural investments to support patient portals are some of the factors expected to restrain the growth of the market to a certain extent.

Target Audience:

• Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Pharmacies, Ambulatory Centers and Outpatient Clinics)
• Healthcare Insurance Companies/Payers
• Healthcare IT Service Providers
• Venture Capitalists
• Corporate Entities
• Accountable Care Organizations

Allscripts Healthcare Solutions, Inc. (U.S.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), CureMD (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Greenway Health, LLC (U.S.), Medfusion (U.S.), Epic Corporation Inc. (U.S.), GE Healthcare (U.K.), and Intelichart (U.S.) are some of the key players in the patient portal market.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/patient-portal-market-49094801.html

Future of Oligonucleotide Synthesis Market Global Forecast to 2022

The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

The global oligonucleotide synthesis market is valued at USD 1.33 Billion in 2016 and is projected to reach USD 2.46 Billion by 2022, at a CAGR of 10.9%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

This report segments the market into product, application, end user, and region

Target Audience for this Report:

• Life science instrumentation and reagent companies
• Pharmaceutical and biotechnology companies
• Hospitals and clinics
• Academic researchers and government research organizations
• Private research institutes
• Custom oligonucleotide service providers
• Contract manufacturing organizations (CMOs)
• Oligonucleotide equipment manufacturers
• Contract research organizations (CROs)
• Market research and consulting firms
• Venture capitalists

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. 

Prominent players in the market include Integrated DNA Technologies (IDT) (US), Sigma-Aldrich Corporation (US) (part of Merck KGaA), Eurogentec (Belgium), Eurofins Genomics (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), BioAutomation (US), LGC Biosearch Technologies (US), GeneDesign (Japan), GE Healthcare (US), TriLink BioTechnologies (US), GenScript (China), Nitto Denko Avecia (US), ATDBio (UK), Bio-Synthesis (US), IBA GmbH (Germany), Gene Link (US), and AITbiotech Pte. (Singapore)

To Know More @ https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

Market Dynamics of Bioabsorbable Stents Market in Upcoming Years

Drivers

• Rapidly Growing Geriatric Population and Increased Risk of CAD and PAD in the Elderly

• Strong Product Pipeline

Restraints

• Presence of Substitutes

Opportunities

• Emerging Markets to Offer High-Growth Opportunities for Market PartiCIPAnts

Challenges

• Product Withdrawals and Failures

• High Risk of Complications

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40983380

Geographically, the Bioabsorbable Stents Market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.

The bioabsorbable stent market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html

Market Analysis & Opportunities of Atherectomy Devices Market by Region

Geographically, atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. 

The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers

.North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American atherectomy devices market.

 However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Stakeholders

• Original equipment manufacturers (OEMs)
• Product sales and distribution companies
• Healthcare service providers (hospitals and surgical centers)
• Non-government organizations
• Government regulatory authorities
• Research laboratories and academic institutes
• Clinical research organizations (CROs)
• Research and development companies
• Market research and consulting firms

To Know More, Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=133112140

Top Industry Players in Medical Aesthetics Market -"Allergan and Cynosure"

Strategic analysis of the market developments between 2015 and 2018 revealed that growth strategies such as product launches, enhancements, and approvals; acquisitions; agreements, partnerships, and collaborations; and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the medical aesthetics market. 

Among these business strategies, product launches, enhancements, and approvals and agreements, partnerships, and collaborations were the two most-widely adopted growth strategies.

The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6% during the forecast period.

Allergan and Cynosure are leading players in Medical Aesthetics Market

Allergan (Ireland) held the leading position in the global facial aesthetics products market in 2017. The company has a broad product portfolio and focuses on continuous innovation and development of new products to sustain its market leadership. Over the past few years, the company enhanced its share in the market by introducing new products and securing approvals for various medical aesthetic products. 

Cynosure (a wholly owned subsidiary of Hologic, US) held the leading position in the global medical aesthetics market for energy & light-based devices in 2017. Cynosure is a prominent manufacturer of laser-based medical aesthetic devices. In 2017, Hologic acquired Cynosure, which helped Hologic to enter the medical aesthetics market. Cynosure has a strong patent portfolio of 37 US patents, and it markets around 14 light/laser-based systems for medical aesthetic applications. 

To Know More, Download FREE Brochure @
https://tinyurl.com/y2qnlo7a

Parkinson’s Disease Treatment Market 2019 Rapidly Growing to Hits $5.69 billion in 2022

Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line treatment for this disease. 

The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%. Rising geriatric population and government funding for research on Parkinson’s disease are the driving factors for this market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region

"Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022"

Currently, a wide range of treatments is available for alleviating the symptoms of Parkinson’s disease. Medication is the first line therapy for treating the disease; however, they are not effective in all stages of the disease. 

In the severe stages, medications do not show pharmacological action in relieving disease symptoms. Neurologists perform thalamotomy, pallidotomy, or implant deep brain stimulation (DBS) devices in order to ease symptoms.

Target Audience for this Report:

• Parkinson’s disease treatment product manufacturers
• Parkinson’s disease treatment dealers and suppliers
• Human identification service providers
• Parkinson’s disease associations
• Academic institutions
• Venture capitalists
• Consulting firms

To Know More @ https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Environmental Monitoring Market 2019 Market Strategy-2021

The environmental monitoring industry is an attractive market for new entrants owing to the significant growth potential offered and high return-on-investment for innovative pollution monitoring products. 

A majority of the key players in environmental monitoring market are following the product development and enhancement strategy. This strategy helps the players to develop innovative, affordable, and portable air and water pollution monitoring products, strengthen their R&D base and distribution networks, and expand into fast-growing emerging nations in Asia-Pacific. 

This strategy also enables market players to meet the growing demand of the consumers

As of 2015, Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Honeywell International Inc. (U.S.), Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), TE Connectivity Ltd. (Switzerland), General Electric Company (U.S.), Emerson Electric Co. (U.S.), Teledyne Technologies Inc. (U.S.), and Merck KGaA (Germany)are some key players operating in the global environmental monitoring market.

New product launches and product enhancements are the key growth strategies adopted by major players to develop their positions in the global environmental monitoring market. 

Moreover, strategies such as strategic acquisitions, geographic expansions, and collaborations were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the environmental monitoring market.

To Know More Visit @ https://www.marketsandmarkets.com/Market-Reports/environmental-monitoring-market-216846315.html

Medtronic (Covidien) & Johnson & Johnson (Ethicon) are the Top Player sin the Specimen Retrieval Market

Growth in Specimen Retrieval Market is mainly driven by the increasing prevalence of diseases requiring surgical treatment and the removal of specimens from the body, especially laparoscopic procedures. However, the high cost of specimen retrieval systems is a major restraint for this market, particularly in emerging countries.

The specimen retrieval market is expected to reach USD 290 million by 2024 from USD 230 million in 2019, at a CAGR of 4.7%. 



Medtronic (Covidien) is a major player in the specimen retrieval market. The company operates in four major segments—Cardiac & Vascular Group, Restorative Therapies Group, Minimally Invasive Therapies Group, and Diabetes Group. The company offers the Reliacatch Specimen Retrieval Bag, Endo Catch Gold Specimen Retrieval Pouch, and EndoBag Specimen Retrieval System through its Minimally Invasive Therapies Group.

Johnson & Johnson (Ethicon) is the largest player in the specimen retrieval market. It has a strong foothold in the specimen retrieval systems market. Ethicon has a strong global distribution network and a good brand reputation among end users. The company’s strong presence and wide distribution channels across the globe have helped it in maintaining its leading position in the specimen retrieval systems market.

The specimen retrieval market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market areTeleflex Incorporated (US), Applied Medical Resources Corporation (US), CONMED Corporation (US), Cooper Surgical, Inc. (US), Genicon (US), B. Braun Melsungen AG (Germany), Laprosurge (UK), Purple Surgical (UK), and Medtronic (Ireland).

 The key growth strategies followed by most companies in the specimen retrieval systems market are acquisitions and agreements. These two strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.

To Know More https://www.marketsandmarkets.com/Market-Reports/specimen-retrieval-market-126359758.html